Replies to post #1779 on 3D Printing Stocks

[BiotechValues]

January/February had a lot of fear/selling due to last year's placement becoming available for sale.

I think those fears have pretty much worked through the stock by now, and private placement shareholders from .01 last year have had ample time to sell if they were going to- and some probably have by now.

But more than anything it's forward events- Q4 should be strong- probably a record for revenue, and SGLB has the $ now for full commercialization of PrintRite3D.

It might not take off from here, but I think downside is limited at this point.

Just my opinion-